• Je něco špatně v tomto záznamu ?

Probing Receptor Specificity by Sampling the Conformational Space of the Insulin-like Growth Factor II C-domain

R. Hexnerová, K. Křížková, M. Fábry, I. Sieglová, K. Kedrová, M. Collinsová, P. Ullrichová, P. Srb, C. Williams, MP. Crump, Z. Tošner, J. Jiráček, V. Veverka, L. Žáková,

. 2016 ; 291 (40) : 21234-21245. [pub] 20160810

Jazyk angličtina Země Spojené státy americké

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc17023785

Insulin and insulin-like growth factors I and II are closely related protein hormones. Their distinct evolution has resulted in different yet overlapping biological functions with insulin becoming a key regulator of metabolism, whereas insulin-like growth factors (IGF)-I/II are major growth factors. Insulin and IGFs cross-bind with different affinities to closely related insulin receptor isoforms A and B (IR-A and IR-B) and insulin-like growth factor type I receptor (IGF-1R). Identification of structural determinants in IGFs and insulin that trigger their specific signaling pathways is of increasing importance in designing receptor-specific analogs with potential therapeutic applications. Here, we developed a straightforward protocol for production of recombinant IGF-II and prepared six IGF-II analogs with IGF-I-like mutations. All modified molecules exhibit significantly reduced affinity toward IR-A, particularly the analogs with a Pro-Gln insertion in the C-domain. Moreover, one of the analogs has enhanced binding affinity for IGF-1R due to a synergistic effect of the Pro-Gln insertion and S29N point mutation. Consequently, this analog has almost a 10-fold higher IGF-1R/IR-A binding specificity in comparison with native IGF-II. The established IGF-II purification protocol allowed for cost-effective isotope labeling required for a detailed NMR structural characterization of IGF-II analogs that revealed a link between the altered binding behavior of selected analogs and conformational rearrangement of their C-domains.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc17023785
003      
CZ-PrNML
005      
20170720122335.0
007      
ta
008      
170720s2016 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1074/jbc.M116.741041 $2 doi
035    __
$a (PubMed)27510031
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Hexnerová, Rozálie $u From the Institute of Organic Chemistry and Biochemistry, Academy of Sciences of the Czech Republic, v.v.i., Flemingovo nám 2, 166 10 Prague 6, Czech Republic, Faculty of Science, Charles University in Prague, Albertov 6, Prague 128 43, Czech Republic.
245    10
$a Probing Receptor Specificity by Sampling the Conformational Space of the Insulin-like Growth Factor II C-domain / $c R. Hexnerová, K. Křížková, M. Fábry, I. Sieglová, K. Kedrová, M. Collinsová, P. Ullrichová, P. Srb, C. Williams, MP. Crump, Z. Tošner, J. Jiráček, V. Veverka, L. Žáková,
520    9_
$a Insulin and insulin-like growth factors I and II are closely related protein hormones. Their distinct evolution has resulted in different yet overlapping biological functions with insulin becoming a key regulator of metabolism, whereas insulin-like growth factors (IGF)-I/II are major growth factors. Insulin and IGFs cross-bind with different affinities to closely related insulin receptor isoforms A and B (IR-A and IR-B) and insulin-like growth factor type I receptor (IGF-1R). Identification of structural determinants in IGFs and insulin that trigger their specific signaling pathways is of increasing importance in designing receptor-specific analogs with potential therapeutic applications. Here, we developed a straightforward protocol for production of recombinant IGF-II and prepared six IGF-II analogs with IGF-I-like mutations. All modified molecules exhibit significantly reduced affinity toward IR-A, particularly the analogs with a Pro-Gln insertion in the C-domain. Moreover, one of the analogs has enhanced binding affinity for IGF-1R due to a synergistic effect of the Pro-Gln insertion and S29N point mutation. Consequently, this analog has almost a 10-fold higher IGF-1R/IR-A binding specificity in comparison with native IGF-II. The established IGF-II purification protocol allowed for cost-effective isotope labeling required for a detailed NMR structural characterization of IGF-II analogs that revealed a link between the altered binding behavior of selected analogs and conformational rearrangement of their C-domains.
650    _2
$a substituce aminokyselin $7 D019943
650    _2
$a CD antigeny $x chemie $x genetika $x metabolismus $7 D015703
650    _2
$a lidé $7 D006801
650    _2
$a insulinu podobný růstový faktor II $x chemie $x genetika $x metabolismus $7 D007335
650    _2
$a missense mutace $7 D020125
650    _2
$a proteinové domény $7 D000072417
650    _2
$a protein - isoformy $x chemie $x genetika $x metabolismus $7 D020033
650    _2
$a receptor IGF typ 1 $x chemie $x genetika $x metabolismus $7 D017526
650    _2
$a receptor inzulinu $x chemie $x genetika $x metabolismus $7 D011972
650    _2
$a rekombinantní proteiny $x chemie $x genetika $x metabolismus $7 D011994
655    _2
$a časopisecké články $7 D016428
700    1_
$a Křížková, Květoslava $u From the Institute of Organic Chemistry and Biochemistry, Academy of Sciences of the Czech Republic, v.v.i., Flemingovo nám 2, 166 10 Prague 6, Czech Republic, Faculty of Science, Charles University in Prague, Albertov 6, Prague 128 43, Czech Republic.
700    1_
$a Fábry, Milan $u From the Institute of Organic Chemistry and Biochemistry, Academy of Sciences of the Czech Republic, v.v.i., Flemingovo nám 2, 166 10 Prague 6, Czech Republic, Institute of Molecular Genetics, Academy of Sciences of the Czech Republic, v.v.i., Vídeňská 1083, 142 20 Prague 4, Czech Republic, and.
700    1_
$a Sieglová, Irena $u From the Institute of Organic Chemistry and Biochemistry, Academy of Sciences of the Czech Republic, v.v.i., Flemingovo nám 2, 166 10 Prague 6, Czech Republic.
700    1_
$a Kedrová, Kateřina $u From the Institute of Organic Chemistry and Biochemistry, Academy of Sciences of the Czech Republic, v.v.i., Flemingovo nám 2, 166 10 Prague 6, Czech Republic, Faculty of Science, Charles University in Prague, Albertov 6, Prague 128 43, Czech Republic.
700    1_
$a Collinsová, Michaela $u From the Institute of Organic Chemistry and Biochemistry, Academy of Sciences of the Czech Republic, v.v.i., Flemingovo nám 2, 166 10 Prague 6, Czech Republic.
700    1_
$a Ullrichová, Pavlína $u Department of Analytical Chemistry, University of Chemistry and Technology, Technická 5, 166 28 Prague 6, Czech Republic.
700    1_
$a Srb, Pavel $u From the Institute of Organic Chemistry and Biochemistry, Academy of Sciences of the Czech Republic, v.v.i., Flemingovo nám 2, 166 10 Prague 6, Czech Republic.
700    1_
$a Williams, Christopher $u Department of Organic and Biological Chemistry, School of Chemistry, Cantock's Close, University of Bristol, Bristol BS8 1TS, United Kingdom.
700    1_
$a Crump, Matthew P $u Department of Organic and Biological Chemistry, School of Chemistry, Cantock's Close, University of Bristol, Bristol BS8 1TS, United Kingdom.
700    1_
$a Tošner, Zdeněk $u Faculty of Science, Charles University in Prague, Albertov 6, Prague 128 43, Czech Republic.
700    1_
$a Jiráček, Jiří $u From the Institute of Organic Chemistry and Biochemistry, Academy of Sciences of the Czech Republic, v.v.i., Flemingovo nám 2, 166 10 Prague 6, Czech Republic.
700    1_
$a Veverka, Václav $u From the Institute of Organic Chemistry and Biochemistry, Academy of Sciences of the Czech Republic, v.v.i., Flemingovo nám 2, 166 10 Prague 6, Czech Republic, vaclav.veverka@uochb.cas.cz.
700    1_
$a Žáková, Lenka $u From the Institute of Organic Chemistry and Biochemistry, Academy of Sciences of the Czech Republic, v.v.i., Flemingovo nám 2, 166 10 Prague 6, Czech Republic, zakova@uochb.cas.cz.
773    0_
$w MED00002546 $t The Journal of biological chemistry $x 1083-351X $g Roč. 291, č. 40 (2016), s. 21234-21245
856    41
$u https://pubmed.ncbi.nlm.nih.gov/27510031 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20170720 $b ABA008
991    __
$a 20170720122828 $b ABA008
999    __
$a ok $b bmc $g 1239466 $s 984698
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2016 $b 291 $c 40 $d 21234-21245 $e 20160810 $i 1083-351X $m The Journal of biological chemistry $n J Biol Chem $x MED00002546
LZP    __
$a Pubmed-20170720

Najít záznam

Citační ukazatele

Nahrávání dat ...

    Možnosti archivace